Speaker Details

Yevgeniy Semenov, MD, MS, FAAD

Yevgeniy Semenov, MD, MS, FAAD

Massachusetts General Hospital, Harvard Medical School

BIOGRAPHY

Dr. Yevgeniy (“Eugene”) R. Semenov, MD, PhD is an Assistant Professor of Dermatology at Massachusetts General Hospital and Harvard Medical School, and Co-Director of the Oncodermatology Program at MGH. He is a board-certified dermatologist and physician-scientist whose work focuses on the intersection of dermatology, artificial intelligence, and precision medicine, with a particular emphasis on cutaneous oncology and melanoma. Dr. Semenov received his undergraduate training in Applied Mathematics and Statistics and a master’s degree in Applied Economics, followed by his medical degree, from Johns Hopkins University. He completed residency training in Dermatology at Washington University School of Medicine. His clinical expertise centers on melanoma and supportive oncodermatology, caring for patients across the spectrum of cancer-associated skin disease. He is the Principal Investigator of the NIH- and DoD-funded Dermatology Clinical Informatics Laboratory, an Investigator in the Laboratory of Systems Pharmacology within Harvard Medical School’s Department of Therapeutic Sciences, and a member of the Harvard Data Science Initiative. His research leverages large multi-institutional datasets, digital histopathology, and machine learning to develop and validate AI-enabled tools for risk stratification, outcome prediction, and precision care in dermatologic oncology.

SESSIONS

U067 “Bread n’ Butter with a Side of Nutella”: Short n’ Sweet, High-Yield Updates on Management of Bread n’ Butter Dermatologic Diseases
Mar 29, 2026 8:00 AM - 9:00 AM Four Seasons 3
S050 The 2026 Debates: Controversies in Dermatology
Mar 30, 2026 9:00 AM - 12:00 PM Bluebird 3E
S055 Chronic Pruritus: Bedside to Bench Perspectives
Mar 30, 2026 9:00 AM - 12:00 PM Bluebird 2E

DISCLOSURES

Alterome Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Galderma – Advisory Board(Honoraria); Journal of the American Academy of Dermatology – Other(Salary); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Pyxis Oncology – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);